U.S. Markets closed

Indiva Limited (NDVAF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.1900+0.0097 (+5.38%)
At close: 3:37PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.1803
Open0.1855
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.1855 - 0.1917
52 Week Range0.1140 - 0.3400
Volume40,717
Avg. Volume17,900
Market Cap21.14M
Beta (5Y Monthly)2.34
PE Ratio (TTM)N/A
EPS (TTM)-0.0930
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire

    BC Craft Supply Co. Introduces New BC Grown Cultivar From Vodis Pharmaceuticals Inc.

    VANCOUVER, British Columbia, Oct. 14, 2020 (GLOBE NEWSWIRE) -- BC Craft Supply Co. Ltd. (the “Company” or “BC Craft”) (CSE:CRFT) (FSE:ZZD1) is pleased to announce a new and exciting BC cultivar into its supply chain; Meat Breath from Vodis Pharmaceuticals Inc. (“Vodis”) (CSE:VP) (OTC:VDQSF) is a rare and evenly balanced hybrid cannabis strain. This is Vodis’ first go-to-market crop which has been purchased by BC Craft and shipped to Indiva Limited (“Indiva”) (TSXV:NDVA) (OTCQX:NDVAF) for processing under a master processing agreement (“MPA”) that was announced on May 13, 2020. Under the MPA, the dried flower will be processed into Indiva’s new premium brand, Artisan Batch, and packaged in beautiful 3.5 gram jars. Artisan Batch features strains from craft and micro growers across Canada, who pride themselves on the quality, potency, and terpene profile of their strains.  Vodis is a licensed cannabis producer and processor located in Delta, BC. Their brand is Gnomestar Craft Cannabis and all dried flower products are hand-harvested, hang dried and hand trimmed for the most discerning cannabis consumer. Mark Lotz, CEO of Vodis states, “Our relationship with BC Craft marks a turning point – our first sale. Our entire team is extremely proud of this accomplishment. We are grateful to be partnered with BC Craft and we hope customers appreciate the amount of care that goes into the cultivation of our flower.” Mike Picken, Vodis’ head grower who painstakingly tended and oversaw every aspect of growing Meat Breath added, “No detail has been overlooked to ensure the consumer gets the best product possible. Adapting to the needs of the plant at every stage of its life-cycle is key to getting the utmost from these carefully selected genetics.” Meat Breath is a truly eye-catching cannabis strain and with Vodis’ testing at over 23.8% THC and 2.7% terpene profile, it’s sure to leave a lasting impression in today’s legal market. Matthew Watters, CEO of BC Craft further states, “The Vodis team have cultivated a beautiful, high-end artisanal dried flower that connoisseurs of premier cannabis are sure to enjoy in the Canadian recreational market, we cannot wait until Meat Breath is available on store shelves shortly.”ABOUT BC CRAFT SUPPLY CO.Based in Vancouver, British Columbia, BC Craft Supply Co. has aggregated the best legacy-era talent from Canada's craft cannabis industry, which boasts an international reputation. The team at BC Craft supports the most trusted cannabis cultivators in Canada to transition into their supply chain, bringing with them their unique cultivars and years of experience with the plant. In exchange for support with licensing, compliance and distribution, cultivators will sign on as a BC Craft supplier. This makes BC Craft uniquely positioned to be the premium cannabis brand in Canada.BC Craft’s subsidiary, Medcann Health Products Ltd., is a Health Canada licensed cultivator and processor with a license to sell medical cannabis products in Canada.Click here to connect with BC Craft Supply Co. on Instagram, Twitter, LinkedIn and Facebook, and click here to find more information on the Company.CONTACTMatthew Watters, Director Phone: 604-687-2038 Email: mwatters@bccraftsupplyco.comDISCLAIMER AND READER ADVISORYNeither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this press release, which has been prepared by management.This news release includes certain “forward-looking statements” under applicable Canadian securities legislation. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. BC Craft disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

  • GlobeNewswire

    Indiva Secures Agreement with Medical Cannabis by Shoppers Inc.

    Medical Cannabis by Shoppers™ portal to offer Bhang® Chocolate and Wana™ Sour GummiesLONDON, Ontario, Oct. 13, 2020 (GLOBE NEWSWIRE) -- Indiva Limited (the “Company” or “Indiva”) (TSXV:NDVA) (OTCQX:NDVAF), a leading Canadian producer of cannabis edibles and other cannabis products, is pleased to announce an agreement has been secured with Medical Cannabis by Shoppers Inc., a subsidiary of Shoppers Drug Mart Inc. This agreement will see Bhang® Chocolate and Wana™ Sour Gummies sold through the Medical Cannabis by Shoppers™ business, including Bhang® THC Milk Chocolate, Bhang® THC Dark Chocolate, Bhang® CBD-Dominant Milk Chocolate, Bhang® Caramel Dark Chocolate THC/CBD 1:1, as well as Wana™ Sour Gummies in the following flavours: Watermelon Hybrid, Strawberry Lemonade 1:1, and Mango Sativa.The Medical Cannabis by Shoppers online platform is a trusted and convenient source of quality medical cannabis, providing patients with single-source access to a broad range of products. Through their national online platform, the Medical Cannabis by Shoppers business connects patients with cannabis products that meet the highest quality and safety standards. The agreement between the Company and Medical Cannabis by Shoppers Inc. will provide Canadian medical cannabis consumers access to Indiva’s market-leading portfolio of cannabis edibles.“We are thrilled about this agreement with Medical Cannabis by Shoppers Inc., which will see our best-in-class cannabis edibles reach the medical cannabis market,” said Niel Marotta, President and CEO of Indiva. “We are eager to give patients across the country access to different forms of medical cannabis. Both Bhang® and Wana™ have reputations as high-quality products, and we are excited to see them become legitimate options for medical cannabis consumers across Canada.”Bhang® Chocolate and Wana™ Sour Gummies are expected to be for sale online through the Medical Cannabis by Shoppers site (shoppersdrugmart.ca/cannabis) in the coming days.ABOUT INDIVAIndiva sets the standard for quality and innovation in cannabis. As a Canadian licensed producer, Indiva creates premium pre-rolls, flower, capsules, and edible products and provides production and manufacturing services to peer entities. In Canada, Indiva produces and distributes the award-winning Bhang® Chocolate, Wana™ Sour Gummies, Ruby® Cannabis Sugar, Sapphire™ Cannabis Salt, Artisan Batch, and other Powered by INDIVA™ products through license agreements and partnerships. Click here to connect with Indiva on LinkedIn, Instagram, Twitter and Facebook, and here to find more information on the Company and its products.CONTACTSMEDIA CONTACT Meagan Kelly, Marketing and Communications Specialist Phone: 613-979-6347 Email: mkelly@indiva.comINVESTOR CONTACT Anthony Simone Phone: 416-881-5154 Email: ir@indiva.comSteve Low Phone: 647-620-5101 Email: stevelow@indiva.comDISCLAIMER AND READER ADVISORYNeither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) has in any way passed upon the merits of the contents of this press release and neither of the foregoing entities accepts responsibility for the adequacy or accuracy of this release or has in any way approved or disapproved of the contents of this press release.Certain statements contained in this press release constitute forward-looking information. These statements relate to future events or future performance. The use of any of the words “could”, “intend”, “expect”, “believe”, “will”, “projected”, “estimated” and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the parties’ current belief or assumptions as to the outcome and timing of such future events. Actual future results may differ materially. In particular, this release contains forward-looking information relating to the Company's future operations, future product offerings and compliance with applicable regulations. Various assumptions or factors are typically applied in drawing conclusions or making the forecasts or projections set out in forward-looking information. Those assumptions and factors are based on information currently available to the parties. The material factors and assumptions include the parties being able to maintain the necessary regulatory and other third parties’ approvals and licensing and other risks associated with regulated entities in the cannabis industry. The forward-looking information contained in this release is made as of the date hereof and the parties are not obligated to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Because of the risks, uncertainties and assumptions contained herein, investors should not place undue reliance on forward looking information. The foregoing statements expressly qualify any forward-looking information contained herein.This press release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available. Not for distribution to U.S. Newswire Services or for dissemination in the United States. Any failure to comply with this restriction may constitute a violation of U.S. Securities laws.

  • GlobeNewswire

    Indiva Provides Guidance of Record Net Revenue for Fiscal Q3 2020

    Indiva Leads the Edibles MarketLONDON, Ontario, Oct. 06, 2020 (GLOBE NEWSWIRE) -- Indiva Limited (the “Company” or “Indiva”) (TSXV:NDVA) (OTCQX:NDVAF), the parent company of Indiva Inc. (the “Company” or “Indiva”), a leading Canadian producer of cannabis edibles and other cannabis products, is pleased to announce that it expects record net revenue in fiscal Q3 2020 in the range of $2.8 to $3.1 million. This represents over 1,400% year-over-year and 9% sequential net revenue growth at the low end of the revenue guidance range, when compared with net revenue previously reported of $0.19 million and $2.56 million in fiscal Q3 2019 and fiscal Q2 2020 respectively. The month of September also saw record monthly net revenue for Indiva. The increase in net revenue in fiscal Q3 2020 was driven primarily by the national rollout of Wana™ Sour Gummies, which became available in four provinces and one territory in September 2020, as well as the continued popularity of Indiva’s other edible and 2.0 products, including Bhang® Chocolate.    Indiva held leading market share of 28.8% in the edibles category in the province of Ontario, for the month of September.Looking forward, Indiva expects continued year-over-year and sequential net revenue growth into fiscal Q4, based on the strength of our product performance, purchase orders received for existing SKUs, and the planned introduction of new edible products and flavours.“We are delighted with the initial rollout of Wana™ Sour Gummies, and the overall performance of our edible products since our first SKUs were introduced in February 2020. To have achieved leading market share in the edibles category in such a short period of time is a true testament to the Indiva team’s passion, their tireless focus on quality, and the strength of our licensed brands,” said Niel Marotta, President and CEO of Indiva. “Our path to profitability remains on track, and we are excited to continue to introduce more flavours and cannabinoid combinations from our edible lineup, as well as provide new, innovative products to of-age Canadians.”ABOUT INDIVAIndiva sets the standard for quality and innovation in cannabis. As a Canadian licensed producer, Indiva creates premium pre-rolls, flower, capsules, and edible products and provides production and manufacturing services to peer entities. In Canada, Indiva produces and distributes the award-winning Bhang® Chocolate, Wana™ Sour Gummies, Ruby® Cannabis Sugar, Sapphire™ Cannabis Salt, Artisan Batch, and other Powered by INDIVA™ products through license agreements and partnerships. Click here to connect with Indiva on LinkedIn, Instagram, Twitter and Facebook, and here to find more information on the Company and its products.CONTACTSMEDIA CONTACT Meagan Kelly, Marketing and Communications Specialist Phone: 613-979-6347 Email: mkelly@indiva.comINVESTOR CONTACT Anthony Simone Phone: 416-881-5154 Email: ir@indiva.comSteve Low Phone: 647-620-5101 Email: stevelow@indiva.comDISCLAIMER AND READER ADVISORYNeither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) has in any way passed upon the merits of the contents of this press release and neither of the foregoing entities accepts responsibility for the adequacy or accuracy of this release or has in any way approved or disapproved of the contents of this press release.Certain statements contained in this press release constitute forward-looking information. These statements relate to future events or future performance. The use of any of the words “could”, “intend”, “expect”, “believe”, “will”, “projected”, “estimated” and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the parties’ current belief or assumptions as to the outcome and timing of such future events. Actual future results may differ materially. In particular, this release contains forward-looking information relating to the Company's future operations, future product offerings, future sales and revenue, the completion and receipt of payment of all purchase orders, the cost savings and efficiencies materializing as anticipated and compliance with applicable regulations. Various assumptions or factors are typically applied in drawing conclusions or making the forecasts or projections set out in forward-looking information. Those assumptions and factors are based on information currently available to the parties. The material factors and assumptions include the Company being able to maintain the necessary regulatory and other third parties’ approvals and licensing, achieving its projected revenues, cost saving initiatives have the desired results and other risks associated with regulated entities in the cannabis industry. The forward-looking information contained in this release is made as of the date hereof and the parties are not obligated to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Because of the risks, uncertainties and assumptions contained herein, investors should not place undue reliance on forward looking information. The foregoing statements expressly qualify any forward-looking information contained herein.This press release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available. Not for distribution to U.S. Newswire Services or for dissemination in the United States. Any failure to comply with this restriction may constitute a violation of U.S. Securities laws.